LUMO - Lumos Pharma, Inc.

Analysis of Lumos Pharma, Inc.(LUMO), Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and comme

Lumos Pharma, Inc.

LUMO

NASDAQ

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

2.77 USD

-0.03 (-1.08%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Upgrades & Downgrades

We are unable to load this data!

Price PriceTargets

We are unable to load the data!

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.